A Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of E2006 in Healthy Adult and Elderly Subjects
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2013
At a glance
- Drugs Lemborexant (Primary)
- Indications Insomnia
- Focus Adverse reactions
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Apr 2013 Planned End Date changed from 1 May 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 25 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.